ADAC Laboratories, a manufacturer of nuclear medicine and radiation therapy planning systems, believes it is tapping into a new market for CT simulation products with the introduction of its SmartSim package. SmartSim is an integrated CT simulation and
ADAC Laboratories, a manufacturer of nuclear medicine and radiation therapy planning systems, believes it is tapping into a new market for CT simulation products with the introduction of its SmartSim package.
SmartSim is an integrated CT simulation and radiation therapy planning package that speeds up the radiation treatment planning process. The SmartSim package is used with ADACs Pinnacle3 radiation therapy planning system.
SmartSim software reconstructs data gathered from CT scans into 3-D images and digitally reconstructed radiographs. This allows radiation oncologists to more accurately pinpoint the location, size, and shape of tumors. Clinicians are then able to determine optimal radiation beam placements to treat cancerous cells while minimizing the risk to nearby healthy tissue, the firm reports. The program uses a single database for simulation and planning.
Shipments of SmartSim began this month. The company expects the market for CT stimulation products to reach about $100 million this year as radiation oncologists use the technology in place of conventional x-ray simulation.
Can Innovations with AI Help Address the Impact of Staffing Shortages on Radiology Workflow?
October 7th 2024While staffing shortages in radiology continue to persist after the COVID-19 pandemic, current and emerging innovations powered by artificial intelligence (AI) may help facilities navigate these challenges and mitigate rising costs of health care.
CT Study Links Pleural Effusion and Higher 30-Day Mortality Rates in Patients with COVID-19
October 1st 2024In a multicenter study of over 1,100 patients with COVID-19, pleural effusion was detected on CT scans in nearly a third of patients, who also had significantly higher ICU admission and 30-day mortality rates.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.